Ipratropium/Salbutamol Comparator Versus Originator for Chronic Obstructive Pulmonary Disease Exacerbations: USA Observational Cohort Study Using the Clinformatics™ Health Claims Database
Crossref DOI link: https://doi.org/10.1007/s41030-017-0041-7
Published Online: 2017-04-24
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thomas, Vicky
Gefen, Eran
Gopalan, Gokul
Mares, Rafael
McDonald, Rosie
Wan Yau Ming, Simon
Price, David B. http://orcid.org/0000-0002-9728-9992
Funding for this research was provided by:
Teva Branded Pharmaceutical Products, R&D, Inc. (N/A)